Compare Novartis AG (NVS) vs Workiva Inc (WK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Workiva Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Workiva Inc trades at $55.02 (market cap $3.21B). The key difference: Novartis AG is far larger — about 90.4× Workiva Inc's market cap, and Novartis AG pays a 3.17% dividend while Workiva Inc pays none. Which is the better fit depends on your goals.
| NVS | WK | |
|---|---|---|
Market Cap | $290.25B | $3.21B |
Sector | Health | Technology |
52-Week High | $168.62 | $93.31 |
52-Week Low | $113.50 | $44.31 |
Enterprise Value | $330.27B | $3.14B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Workiva Inc
Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →
